Neuroimmune crosstalk in the pathophysiology of hypertension

L Calvillo, MM Gironacci, L Crotti, PL Meroni… - Nature reviews …, 2019 - nature.com
Hypertension is an important risk factor for cardiovascular morbidity and mortality and for
events such as myocardial infarction, stroke, heart failure and chronic kidney disease and is …

Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs

M Liu, X Long, J Xu, M Chen, H Yang, X Guo… - Pharmacological …, 2022 - Elsevier
Long-term elevated blood pressure will increase the cardiac load and lead to myocardial
fibrosis (MF). A variety of pathological mechanisms and signal transduction pathways are …

Doxorubicin-induced myocardial fibrosis involves the neurokinin-1 receptor and direct effects on cardiac fibroblasts

SP Levick, DR Soto-Pantoja, J Bi, WG Hundley… - Heart, Lung and …, 2019 - Elsevier
Background Cancer patients receiving anthracycline-based chemotherapy (Anth-bC) may
experience early cardiac fibrosis, which could be an important contributing mechanism to …

[HTML][HTML] Neuropeptides substance P and calcitonin gene related peptide accelerate the development and fibrogenesis of endometriosis

D Yan, X Liu, SW Guo - Scientific Reports, 2019 - nature.com
Endometriotic lesions are known to be hyperinnervated, especially in lesions of deep
endometriosis (DE), which are frequently in close proximity to various nerve plexuses. DE …

Do DPP-4 inhibitors cause heart failure events by promoting adrenergically mediated cardiotoxicity? Clues from laboratory models and clinical trials

M Packer - Circulation research, 2018 - Am Heart Assoc
Rationale: DPP-4 (dipeptidyl peptidase-4) inhibitors have increased the risk of heart failure
events in both randomized clinical trials and observational studies, but the mechanisms that …

[HTML][HTML] DPP-4 inhibitors as potential candidates for antihypertensive therapy: improving vascular inflammation and assisting the action of traditional antihypertensive …

J Zhang, Q Chen, J Zhong, C Liu, B Zheng… - Frontiers in …, 2019 - frontiersin.org
Dipeptidyl peptidase-4 (DPP-4) is an important protease that is widely expressed on the
surface of human cells and plays a key role in immune-regulation, inflammation, oxidative …

[HTML][HTML] Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism

CN Hsu, CF Hsuan, D Liao, JKJ Chang, AJW Chang… - Life, 2023 - mdpi.com
Diabetic patients have a two-to four-fold increase in the risk of heart failure (HF), and the co-
existence of diabetes and HF is associated with poor prognosis. In randomized clinical trials …

[HTML][HTML] Mast cells: key contributors to cardiac fibrosis

SP Levick, A Widiapradja - International journal of molecular sciences, 2018 - mdpi.com
Historically, increased numbers of mast cells have been associated with fibrosis in
numerous cardiac pathologies, implicating mast cells in the development of cardiac fibrosis …

[HTML][HTML] Replacement of lost substance P reduces fibrosis in the diabetic heart by preventing adverse fibroblast and macrophage phenotype changes

A Widiapradja, AO Kasparian, SL McCaffrey, LL Kolb… - Cells, 2021 - mdpi.com
Reduced levels of the sensory nerve neuropeptide substance P (SP) have been reported in
the diabetic rat heart, the consequence being a loss of cardioprotection in response to …

[HTML][HTML] Neurokinin-1 receptor as a potential drug target for COVID-19 treatment

R Mehboob - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract Novel Coronavirus infection (COVID-19) has become a pandemic in these days. It
is an acute respiratory and infectious disease with no known etiology and treatment. It is …